Taxotere Permanent Baldness

Taxotere Permanent Hair Loss Lawsuit

Loncar Associates is now accepting cases of Taxotere chemotherapy treatment causing permanent hair loss

Taxotere injection concentrate, approved by the FDA on May 14, 1996, is a form of chemotherapy used for the treatment of breast cancer, non-small cell lung cancer, hormone refractory prostate cancer, gastric adenocarcinoma, squamous cell carcinoma of the head, and neck cancer. Use of Taxotere has been linked to permanent hair loss without proper warning and with other, potentially superior, treatments available.

If you or someone you love has experienced permanent hair loss as a result of taking Taxotere, you may be eligible for compensation. Contact Loncar Associates immediately for a free, confidential case evaluation using the form or by calling toll free at 800.285.4878. Taxotere permanent baldness lawsuits are being evaluated on a contingency fee basis, meaning you pay nothing unless a recovery is obtained.

Taxotere FDA Warnings

Manufactured by France-based Sanofi Aventis, Taxotere underwent an FDA label revision in December 2015 adding a warning of permanent alopecia (also known as permanent hair loss) due to a significant number of cases of permanent hair loss being reported to the FDA.

Studies Link Taxotere to Permanent Hair Loss

Multiple studies have also confirmed the link between Taxotere and permanent hair loss. A study published February 14, 2012 concluded, “severe and permanent female hair loss, especially scalp alopecia, is a new and rare cutaneous side-effect of the sequential FEC–docetaxel regimen used for early breast cancer adjuvant treatment”. On top of that, the drug-maker’s own studies estimate that 3% of patients experience persistent or permanent hair loss.

Did Manufacturers Know?

Taxotere in Europe and Canada contained warnings of permanent hair loss as early as 2005 and 2012 respectively. Why it took so long for the FDA & manufacturers to warn users remains a mystery, particularly when there is a more effective, American-made product, Taxol that is at least as effective if not more effective than Taxotere at treating cancer. In attempting to compete with Taxol, which is manufactured by American-based Bristol-Myers Squibb, Sanofi Aventis created Taxotere which is a semi-synthetic analogue of Taxol with twice the potency. Although Taxotere has double the strength of Taxol , the effectiveness remains similar while exposing patients to increased toxicity. This increased toxicity is the primary cause of permanent baldness seen using Taxotere over comparable treatments.

Many patients taking Taxotere were told that their hair loss would only be temporary, when in fact it appears to be permanent in certain cases. Patients were not adequately warned about this severe side effect. It is believed that the manufacturers had knowledge of this risk of permanent hair loss but failed to disclose it. This failure to adequately warn patients deprived them of their ability to choose alternative chemotherapy drugs such as Taxol that are arguably more effective without the risk of permanent hair loss.Had the France-based Sanofi Aventis honestly described its side effects, most women would probably have elected to use the American-made product that is just as effective without the permanent hair loss.

If you or someone you love has experienced permanent hair loss as a result of taking Taxotere, you may be eligible for compensation. Contact Loncar Associates immediately for a free, confidential case evaluation using the form or by calling toll free at 800.285.4878. Taxotere permanent baldness lawsuits are being evaluated on a contingency fee basis, meaning you pay nothing unless a recovery is obtained.

Related Posts